Latest available resultsQuarter ended June 30, 202610-Q · August 7, 2026
Filed with the SECSTERIS plc
STEHealthcare
Next reportNovember 3, 2026Analyst forecast 2.705 $/share
Revenue
$1.49B
▲ +7.3% vs prior year% YoY
Net income
$200.10M
▲ +12.8% vs prior year% YoY
EPS
—
Net margin
13.4%
▲ +0.7 percentage points vs prior year pp YoY
Revenue▲ +7.3 %
Margins (% of revenue)GrossOperatingNet
Net income▲ +12.8 %
EPS
View financial tableQuarter ended June 30, 2026
| Metric | Value | Context |
|---|---|---|
| Operations | ||
| Revenue | $1.49B | |
| Gross profit | $684.20M | 45.8 % |
| Operating income | $285.80M | 19.1 % |
| Net income | $200.10M | 13.4 % |
| R&D | $28.60M | 1.9 % |
| EPS (diluted) | — | |
| Balance sheet | ||
| Assets | $10.74B | |
| Liabilities | $3.51B | |
| Equity | $7.22B | |
| Cash | $482.30M | |
| Capital | ||
| Shares outstanding | 97.50M | as of 2026-08-04 |
| Public float | — | |